Paediatrician calls for HPV jab in pre-teens

Cyprus Mail


August 19, 2009
By Lucy Millett

A LEADING Cypriot paediatrician is calling for all girls as young as 12 to receive the controversial HPV vaccine, which is marketed in Cyprus as Silgard.

According to its makers, pharmaceutical giants Merck, the vaccine protects against human papillomavirus (HPV), which causes the vast majority of cervical cancer cases. It also causes genital warts.

Dr Adamos Hadjipanayis said “The vaccine should be given to all adolescents, especially girls, from 12 years old”. He added: ‘It is best to administer the vaccine before the age of sexual activity. A small percentage of adolescents do become sexually active by the age of 13 so it is important to take the precaution.”

Hadjipanayis said there were two forms of the vaccine available, bivalent and quadrivalent. The bivalent form protects against cervical cancer, he said, while the quadrivalent form protects against both cervical cancer and genital warts. He said the quadrivalent form was 74 per cent effective against cervical cancer and 90 per cent effective against genital warts.

He went on to say that the vaccine was “very safe” with “no serious adverse reaction”.



Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.